IPOPLUS

411.85

-4.6 -1.10%

18 Jun 2026

NSE Listed · Pharmaceuticals

Biocon Ltd. (BIOCON)

Volume: 78,000Avg Vol 1W: 3,92,866Avg Vol 1M: 13,08,94652W Range:331440.4
₹411.85 1.10%
Key Ratios
Updated 7h ago
Market Cap₹67,478 Cr
Current Price₹411.85
Previous Close₹416.45
High / Low (52w)₹440.4 / ₹331
Volume78,000
Avg Vol (1W)3,92,866
Avg Vol (1M)13,08,946
Stock P/E
Book Value₹209.94
Dividend Yield0.12%
ROE1.14%
ROA0.58%
Revenue (TTM)
Revenue Growth3.43%
Profit Margin2.3%
Total Debt₹12,405 Cr
Shares Outstanding162 Cr
Face Value₹5
EPS (TTM)₹0.79
P/B1.98
Debt / Equity0.45
50 DMA₹421.16
200 DMA₹383.7
Day change-1.10%
Price Chart
411.85 13.05% · 1Y
4363401.6Cr
2025-10-21
2026-06-16

20-day avg volume: 12.0L shares

Pros
  • Company is almost debt-free.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹4,517 Cr₹4,173 Cr₹4,296 Cr₹3,942 Cr₹4,417 Cr₹3,821 Cr₹3,590 Cr₹3,433 Cr₹3,917 Cr₹3,954 Cr₹3,462 Cr₹3,423 Cr₹3,774 Cr₹2,941 Cr₹2,320 Cr₹2,140 Cr₹2,409 Cr₹2,174 Cr₹1,840 Cr₹1,761 Cr₹1,842 Cr₹1,857 Cr₹1,750 Cr₹1,694 Cr₹1,558 Cr
EBITDA₹559 Cr₹436 Cr₹455 Cr₹374 Cr₹679 Cr₹361 Cr₹298 Cr₹1,350 Cr₹558 Cr₹1,078 Cr₹510 Cr₹450 Cr₹789 Cr₹422 Cr₹304 Cr₹260 Cr₹447 Cr₹331 Cr₹349 Cr₹242 Cr₹457 Cr₹241 Cr₹229 Cr₹265 Cr₹229 Cr
Net Profit₹126 Cr₹144 Cr₹85 Cr₹31 Cr₹345 Cr₹25 Cr₹-16 Cr₹660 Cr₹136 Cr₹660 Cr₹126 Cr₹101 Cr₹313 Cr₹-42 Cr₹47 Cr₹144 Cr₹239 Cr₹187 Cr₹138 Cr₹84 Cr₹253 Cr₹169 Cr₹169 Cr₹149 Cr₹123 Cr
EPS0.791.070.650.262.870.21-0.135.511.135.511.050.852.62-0.350.391.211.991.561.160.712.121.41.371.251.04
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹16,470 Cr₹15,621 Cr₹11,550 Cr₹8,397 Cr₹7,398 Cr₹6,462 Cr
EBITDA₹2,688 Cr₹2,595 Cr₹1,775 Cr₹1,369 Cr₹1,192 Cr₹1,212 Cr
Net Profit₹1,013 Cr₹1,023 Cr₹463 Cr₹648 Cr₹741 Cr₹748 Cr
EPS8.468.543.875.426.196.3
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹58,797 Cr₹13,768 Cr₹52,043 Cr₹20,394 Cr₹18,522 Cr₹14,444 Cr
Total Liabilities₹31,085 Cr₹2,856 Cr₹29,554 Cr₹10,924 Cr₹10,015 Cr₹7,061 Cr
Equity₹27,713 Cr₹10,912 Cr₹22,489 Cr₹9,470 Cr₹8,508 Cr₹7,383 Cr
Total Debt₹12,405 Cr₹2,041 Cr₹15,291 Cr₹3,999 Cr₹2,962 Cr₹1,222 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹4,521 Cr₹3,246 Cr₹2,081 Cr₹1,439 Cr₹1,354 Cr₹1,627 Cr
Investing₹-234 Cr₹-1,004 Cr₹-14,282 Cr₹-1,699 Cr₹-3,625 Cr₹-1,559 Cr
Financing₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr₹388 Cr
Free Cash Flow₹4,521 Cr₹3,246 Cr₹2,081 Cr₹1,439 Cr₹1,354 Cr₹1,627 Cr
Shareholding
Promoter 44.91% Institutions 31.59% Public 23.32%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search